11116 Federal Register / Vol. 60, No. 40 / Wednesday, March 1, 1995 / Notices

Administration (DEA) for registration as

a bulk manufacturer of the basic classes

of controlled substances listed below:

Drug Schedule

Tetrahydrocannabinols (7370) ..... I

Morphine (9300) ........................... II

The firm plans to manufacture

Tetrahydrocannabinols and a derivative

of Morphine for use in diagnostic kits.

Any other such applicant and any

person who is presently registered with

DEA to manufacture such substances

may file comments or objections to the

issuance of the above application and

may also file a written request for a

hearing thereon in accordance with 21

CFR 1301.54 and in the form prescribed

by 21 CFR 1316.47.

Any such comments, objections, or

requests for a hearing may be addressed

to the Deputy Assistant Administrator,

Office of Diversion Control, Drug

Enforcement Administration, United

States Department of Justice,

Washington, DC 20537, Attention: DEA

Federal Register Representative (CCR),

and must be filed no later than March

31, 1995.

Dated: February 17, 1995.

Gene R. Haislip,

Deputy Assistant Administrator, Office of

Diversion Control, Drug Enforcement

Administration.

[FR Doc. 95–4934 Filed 2–28–95; 8:45 am]

BILLING CODE 4410–09–M

Manufacturer of Controlled

Substances; Registration

By Notice dated April 25, 1994, and

published in the Federal Register on

May 4, 1994, (59 FR 23082), Penick

Corporation, 158 Mount Olivet Avenue,

Newark, New Jersey 07114, made

application to the Drug Enforcement

Administration to be registered as a bulk

manufacturer of the basic classes of

controlled substances listed below:

Drug Schedule

Tetrahydrocannabinols (7370) ..... I

Dihydromorphine (9145) .............. I

Pholcodine (9314) ........................ I

Alphacetylmethadol (9603) .......... I

Cocaine (9041) ............................ II

Codeine (9050) ............................ II

Dihydrocodeine (9120) ................. II

Oxycodone (9143) ....................... II

Hydromorphone (9150) ................ II

Diphenoxylate (9170) ................... II

Benzoylecgonine (9180) .............. II

Ethylmorphine (9190) ................... II

Hydrocodone (9193) .................... II

Meperidine (9230) ........................ II

Methadone (9250) ........................ II

Methadone-intermediate (9254) ... II

Drug Schedule

Dextropropoxyphene, bulk (nondosage forms) (9273).II

Morphine (9300) ........................... II

Thebaine (9333) ........................... II

Opium extracts (9610) ................. II

Opium fluid extract (9620) ........... II

Opium tincture (9630) .................. II

Opium powdered (9639) .............. II

Opium granulated (9640) ............. II

Oxymorphone (9652) ................... II

Phenazocine (9715) ..................... II

Alfentanil (9737) ........................... II

Sufentanil (9740) .......................... II

Fentanyl (9801) ............................ II

A written request for a hearing was

not received, but a comment was filed

by a registered manufacturer. The

comment was considered, however,

DEA determined that the application

should be approved. Therefore,

pursuant to section 303 of the

Comprehensive Drug Abuse Prevention

and Control Act of 1970 and Title 21,

Code of Federal Regulations,

§ 1301.54(e), Deputy Assistant

Administrator, Office of Diversion

Control, hereby orders that the

application submitted by the above firm

for registration as a bulk manufacturer

of the basic classes of controlled

substances listed above is granted.

Dated: January 24, 1995.

Gene R. Haislip,

Deputy Assistant Administrator, Office of

Diversion Control, Drug Enforcement

Administration.

[FR Doc. 95–4937 Filed 2–28–95; 8:45 am]

BILLING CODE 4410–09–M

Importation of Controlled Substances;

Application

Pursuant to section 1008 of the

Controlled Substances Import and

Export Act (21 U.S.C. 958(i)), the

Attorney General shall, prior to issuing

a registration under this Section to a

bulk manufacturer of a controlled

substance in Schedule I or II and prior

to issuing a regulation under section

1002(a) authorizing the importation of

such a substance, provide

manufacturers holding registrations for

the bulk manufacture of the substance

an opportunity for a hearing.

Therefore, in accordance with

§ 1311.42 of title 21, Code of Federal

Regulations (CFR), notice is hereby

given that on December 13, 1994, Lonza

Riverside, 900 River Road,

Conshohocken, Pennsylvania 19428,

made application to the Drug

Enforcement Administration to be

registered as an importer of

Phenylacetone (8501) a basic class of

controlled substance listed in Schedule

II.

The firm is importing the

Phenylacetone to manufacture

Dextroamphetamine Sulfate.

Any manufacturer holding, or

applying for, registration as a bulk

manufacturer of this basic class of

controlled substance may file written

comments on or objections to the

application described above and may, at

the same time, file a written request for

a hearing on such application in

accordance with 21 CFR 1301.54 in

such form as prescribed by 21 CFR

1316.47.

Any such comments, objections, or

requests for a hearing may be addressed

to the Deputy Assistant Administrator,

Office of Diversion Control, Drug

Enforcement Administration, United

States Department of Justice,

Washington, DC 20537, Attention: DEA

Federal Register Representative (CCR),

and must be filed no later than (30 days

from publication).

This procedure is to be conducted

simultaneously with and independent

of the procedures described in 21 CFR

1311.42 (b), (c), (d), (e), and (f). As noted

in a previous notice at 40 FR 43745–46

(September 23, 1975), all applicants for

registration to import a basic class of

any controlled substance in Schedule I

or II are and will continue to be required

to demonstrate to the Deputy Assistant

Administrator, Office of Diversion

Control, Drug Enforcement

Administration that the requirements

for such registration pursuant to 21

U.S.C. 958(a), 21 U.S.C. 823(a), and 21

CFR 1311.42 (a), (b), (c), (d), (e), and (f)

are satisfied.

Dated: February 17, 1995.

Gene R. Haislip,

Deputy Assistant Administrator, Office of

Diversion Control, Drug Enforcement

Administration.

[FR Doc. 95–4935 Filed 2–28–95; 8:45 am]

BILLING CODE 4410–09–M

DEPARTMENT OF LABOR

Employment and Training

Administration

[TA–W–30,550]

Amended Certification Regarding

Eligibility to Apply for Worker

Adjustment Assistance

Grace Energy Corporation, Dallas, TX

and Grace Petroleum Corporation

Operating at the Following Locations:

TA–W–30,550A Oklahoma, TA–W–

30,550B Texas, TA–W–30,550C

Alabama, TA–W–30,550D Colorado,